Founded in 2022, ThermoMind is a company that has developed a breakthrough method using Dynamic Thermal Imaging and AI to detect vascular abnormalities caused by cancer cells in the early stages of breast cancer. Working with top medical institutions worldwide, ThermoMind's Vision One Device captures the breast area over time and conducts analysis to extract biomarkers. Their goal is to enhance women's health equity by providing a patient-oriented screening process and doctors with a precise analysis of imaging using AI.